Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New elbow replacement surgery to be trialled
“The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising” – Andy Moores.
Two referral clinics given RCVS approval to carry out procedure.

The Royal College of Veterinary Surgeons (RCVS) Ethics Review Panel has given approval for a new elbow replacement surgery for dogs to be trialled at two referral clinics.

The third-generation Biomedtrix TATE elbow replacement surgery is the latest design of the TATE elbow replacement that first came into clinical use in the 2010s.

The new implant has already been in use in a small number of US practices. It includes new instrumentation designed to maximise the accuracy of bone preparation for the implants and a new implant design that is said to offer improved stability.

One of the clinics where it will be trialled is Moores Orthopaedic Clinic in Upton Grey, Hampshire. Andy Moores, clinical director and head of the joint replacement programme at the clinic, recently became certified to perform the third-generation TATE elbow replacement surgery after attending the first TATE technology course in Boston, USA.

The surgery is also available at Wear Referrals in Bradbury, County Durham, as part of the clinical evaluation trial. The practice is currently seeing cases for preliminary assessment for the surgery.

The procedure will be available for suitable patients with severe elbow osteoarthritis. The outcomes of the surgeries will be closely monitored and documented.

Dr Moores said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.

“The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.

“We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this. We look forward to offering this surgery as an option for some of our most painful canine patients.”

Image © Moores Orthopaedic Clinic

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.